DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Look KY, Sandler A, Blessing JA. et al. Gynecologic Oncology Group (GOG) Study.
Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study.
Gynecol Oncol 2004;
92: 644-647
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.